Furthermore, elevated levels of interleukin-17 (IL-17) have been observed in DM patients, and IL-17–producing T cells infiltrate the lesions of both psoriasis and DM, suggesting a contribution of the IL-23/Th17 axis to both diseases (6). The gene discussed is IL23A; the disease is dermatomyositis.